Filing Details
- Accession Number:
- 0001127602-20-006926
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-21 15:52:46
- Reporting Period:
- 2020-02-19
- Accepted Time:
- 2020-02-21 15:52:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1200845 | Jean-Luc Belingard | 531 South Spring Street Burlington NC 27215 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-19 | 3,100 | $77.19 | 41,161 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-19 | 26,479 | $189.76 | 14,682 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2020-02-19 | 3,100 | $0.00 | 3,100 | $77.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-05-12 | 2020-05-12 | No | 4 | M | Direct |
Footnotes
- The price of $189.7636 per share represents a weighted average of sales prices ranging from $189.54 to $189.917 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.